Compare · MDLN vs MMSI
MDLN vs MMSI
Side-by-side comparison of Medline Inc. (MDLN) and Merit Medical Systems Inc. (MMSI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and MMSI operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $47.21B, about 11.8x MMSI ($4.01B).
- Over the past year, MDLN is down 11.9% and MMSI is down 26.9% - MDLN leads by 15.0 points.
- MDLN has been more active in the news (26 items in the past 4 weeks vs 3 for MMSI).
- MDLN has more recent analyst coverage (25 ratings vs 15 for MMSI).
- Company
- Medline Inc.
- Merit Medical Systems Inc.
- Price
- $35.91-1.41%
- $67.23+3.11%
- Market cap
- $47.21B
- $4.01B
- 1M return
- -4.76%
- +5.50%
- 1Y return
- -11.88%
- -26.88%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 26
- 3
- Recent ratings
- 25
- 15
Merit Medical Systems Inc.
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Latest MDLN
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Financial Officer Drazin Michael B covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Commercial Officer Golwas Douglas P covered exercise/tax liability with 1,889 shares, converted options into 100,000 shares, sold $3,677,115 worth of shares (100,000 units at $36.77) as part of a pre-agreed trading plan and returned 100,000 units of Class B Common Stock to the company, increasing direct ownership by 1,319% to 365,864 units (SEC Form 4)
- Chief Executive Officer Boyle James M covered exercise/tax liability with 2,370 shares, decreasing direct ownership by 7% to 29,369 units (SEC Form 4)
- Director Galanti Richard A was granted 16,392 shares (SEC Form 4)
- Director Sweet Thomas W was granted 17,800 shares (SEC Form 4)
Latest MMSI
- CHIEF HUMAN RESOURCES OFFICER Voigt Michel J. gifted 65 shares, decreasing direct ownership by 0.14% to 46,062 units (SEC Form 4)
- CHIEF LEGAL OFFICER, SECRETARY Lloyd Brian G. gifted 2,000 shares, decreasing direct ownership by 3% to 60,132 units (SEC Form 4)
- SEC Form SD filed by Merit Medical Systems Inc.
- Director Gunderson Thomas J. exercised 21,250 shares at a strike of $52.17, increasing direct ownership by 54% to 60,741 units (SEC Form 4)
- Director Ward Lynne N. was granted 3,457 shares, increasing direct ownership by 44% to 11,266 units (SEC Form 4)
- Director Ward Scott R. was granted 3,457 shares (SEC Form 4)
- Director Gunderson Thomas J. was granted 3,457 shares, increasing direct ownership by 10% to 39,491 units (SEC Form 4)
- Director Evans Stephen C. was granted 3,457 shares, increasing direct ownership by 51% to 10,266 units (SEC Form 4)
- Director Kaiser Laura S. was granted 3,457 shares, increasing direct ownership by 35% to 13,352 units (SEC Form 4)
- Director Perez Silvia M. was granted 3,457 shares, increasing direct ownership by 75% to 8,040 units (SEC Form 4)